Metraipolis › archive › dc_964792eda083
Refractory Diabetic Ketoacidosis Associated with Enfortumab Vedotin: A Pharmacokinetic-Based Management Approach — Europe PMC PMID:42295856
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42295856
- DOI
- 10.34067/kid.0000001262
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T10:56:26.028Z
- SHA-256 of the archived text
4726f83b5a5089a9c8160e803fea0ba2b9cdc024bc8e0115d36000c5b44f7501- Stable URL of this page
https://metraipolis.com/documento/dc_964792eda083
How to cite
Refractory Diabetic Ketoacidosis Associated with Enfortumab Vedotin: A Pharmacokinetic-Based Management Approach — Europe PMC PMID:42295856 — Europe PMC (en), https://europepmc.org/article/MED/42295856 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_964792eda083 (Metraipolis archive dc_964792eda083, sha256 4726f83b5a5089a9c8160e803fea0ba2b9cdc024bc8e0115d36000c5b44f7501)
BibTeX
@misc{dc964792eda083,
title = {Refractory Diabetic Ketoacidosis Associated with Enfortumab Vedotin: A Pharmacokinetic-Based Management Approach — Europe PMC PMID:42295856},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42295856},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_964792eda083; sha256 4726f83b5a5089a9c8160e803fea0ba2b9cdc024bc8e0115d36000c5b44f7501},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42295856. Agents can read the archived copy with the MCP tool read_document.